Case Managers help with
Teva’s Shared Solutions® is there for patients when they need support — compassionate, MS-certified nurses are available by phone around the clock, so your COPAXONE® patients will have the support they need.
Teva’s Shared Solutions® understands the importance of making a personal connection with someone who has had similar experiences. Shared Solutions® cares about keeping patients connected with RMS peers so you can be confident that your patients are also receiving support from people who can relate to their experiences living with RMS.
MS Peers are peers with relapsing forms of MS who have been compensated by Teva.
Teva’s Shared Solutions® cares about connecting patients to other patients with MS, healthcare professionals, and field nursing experts who can help educate them about MS and their COPAXONE® therapy. Patients are offered live educational events, webcasts, and teleconferences so you can be confident that your patients are informed and empowered.
†Patients with relapsing forms of MS. MS peers are compensated by Teva.
Injections for 3-times-a-week COPAXONE® 40 mg must be at least 48 hours apart.
COPAXONE® is contraindicated in patients with known hypersensitivity to glatiramer acetate or mannitol.
Approximately 16% of patients exposed to COPAXONE® 20 mg per mL compared to 4% of those on placebo, and approximately 2% of
The website you are about to visit does not belong to Teva Neuroscience, Inc. or follow the same terms of service. Some of these websites may also require a third-party account, subscription, or payment to view.
While we carefully choose which websites we link to, we cannot control any changes or actions made by them. As a result, Teva makes no warranties or representations of any kind as to the accuracy, currency, or completeness of the following site, nor any liability on their behalf.